Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Excellent article about "Final rejection"

The prospects of investors not knowing which of the five avenues selected is disturbing. RG has a mandate to report to the shareholders which could cause an exodus in the short term, or nothing could be done/said for six months in the case of abandonment........I feel we are due a PR with an intended course of action, keeping in mind any amount of language to shift focus to other aspects of PTSC operations may be a indication of whether any announced course of action is simply lipservice........

Share
New Message
Please login to post a reply